5 结果
REFERENCE TO SEQUENCE LISTING
Pursuant to 37 C.F.R. 1.821(c), a sequence listing is submitted herewith via EFS-Web as an ASCII compliant text file named "Sequencelisting.TXT" that was created on Jan. 8, 2013, and has a size of 3557 bytes. The content of the aforementioned file named
This invention relates to compounds having anti-metastatic and/or anti-inflammatory activity, and in particular it relates to the use of these compounds as anti-metastatic and/or anti-inflammatory agents in animals and man.
One of the key events in inflammation and tumour metastasis is the adherence
FIELD OF THE INVENTION
This invention relates to therapeutic compositions for the topical treatment of vital conditions and neoplastic disorders, in particular to a composition in topical form comprising an anti-vital or an anti-neoplastic drug in combination with a potentiating drug which is an
FIELD OF THE INVENTION
The present invention relates to anti-TNF-.alpha. therapy for the mucopolysaccharidoses and other lysosomal disorders.
BACKGROUND OF THE INVENTION
Lysosomal storage disorders represent a group of over 40 distinct genetic diseases and are caused by abnormalities of enzymes
FIELD OF THE INVENTION
The present invention relates to compositions for the protection, treatment, repair, and modulation of inflammation of connective tissues in humans and other animals.
BACKGROUND OF THE INVENTION
The tissues of mammals, including humans, are in a constant state of flux between